[Home ] [Archive]    
:: Home :: About Journal :: Registration :: Article Submission :: Contact us :: Site Map ::
:: Volume 10, Issue 1 (March 2018 2018) ::
IJBC 2018, 10(1): 9-15 Back to browse issues page
Recombinant Human Erythropoietin in Children with Solid Tumors and Chemotherapy-induced Anemia
Amir Ataolah Hiradfar , Azim Rezamand , Matin Pourghasem , Sepideh Karkon Shayan , Behnaz Ghamari , Farid Karkon Shayan *
Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:   (670 Views)
Background: In patients undergoing chemotherapy for cancer, anemia is part of the progression of the disease. Considering the effects of anemia on quality of life of the patients, the prevention and treatment of chemotherapy-induced anemia is crucial. This study was aimed to evaluate the efficacy of recombinant human erythropoietin in reducing the need for blood transfusion in children with solid tumors receiving chemotherapy.
Methods: In a clinical trial, 57 children referred to the pediatric centre of Tabriz University of Medical Sciences with a diagnosis of solid tumor were randomly assigned into two groups. The intervention group (n=29) received recombinant human erythropoietin (rHuEPO) at a dose of 450 IU/kg subcutaneously once a week for 12 weeks, and the control group (n=28) received no intervention in this regard. Hemoglobin levels were analysed at the beginning and end of the study. The need for blood transfusion was also assessed in the patients.
Results: The mean Hb at the beginning of the study was 8.85±1.01 and 8.98±0.11 g in the intervention and control groups, respectively. The mean Hb at the end of the study was 9.78±0.32 g/dl in the intervention group and 7.79±0.24 g/dl in the control group. Hb level was significantly higher in the intervention group at the end of the 12 weeks of treatment with rHuEPO than in the control group (P=0.001).
Conclusion: Based on the results of this study, rHuEPO administration seems to be beneficial in the prevention and treatment of chemotherapy-induced anemia in children with solid tumors and reduces the amount of blood transfusion in these patients.
Keywords: Human recombinant erythropoietin, Anemia, Chemotherapy-induced anemia, Solid tumor, Children, Blood transfusion
Full-Text [PDF 835 kb]   (466 Downloads)    
: Research | Subject: Pediatric Hematology & Oncology
Received: 2018/01/6 | Accepted: 2018/02/28 | Published: 2018/05/7
* Corresponding Author Address: Tabriz University of Medical Sciences, Tabriz, Iran.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA code


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hiradfar A A, Rezamand A, Pourghasem M, Karkon Shayan S, Ghamari B, Karkon Shayan F. Recombinant Human Erythropoietin in Children with Solid Tumors and Chemotherapy-induced Anemia. IJBC. 2018; 10 (1) :9-15
URL: http://ijbc.ir/article-1-779-en.html


Volume 10, Issue 1 (March 2018 2018) Back to browse issues page
مجله ی خون و سرطان ایران Iranian Journal of Blood and Cancer
Persian site map - English site map - Created in 0.07 seconds with 30 queries by YEKTAWEB 3764